Lymphocyte Transformation during Dinitrochlorobenzene Contact Sensitization. AN IN VITRO AND IN VIVO EVALUATION OF THE PRIMARY IMMUNE RESPONSE IN MAN
A. Edgar Miller, William R. Levis
A. Edgar Miller, William R. Levis
Published August 1, 1973
Citation Information: J Clin Invest. 1973;52(8):1925-1930. https://doi.org/10.1172/JCI107376.
View: Text | PDF
Research Article

Lymphocyte Transformation during Dinitrochlorobenzene Contact Sensitization. AN IN VITRO AND IN VIVO EVALUATION OF THE PRIMARY IMMUNE RESPONSE IN MAN

Abstract

An evaluation of cell-mediated immunity in man is described that combines the advantages of an in vitro technique, lymphocyte transformation, with the use of contact sensitization to a primary immunogen, dinitrochlorobenzene (DNCB). DNCB, when coupled to autologous or allogeneic peripheral blood leukocytes, forms a complex, DNCB-antigen, that induces lymphocyte transformation specifically in leukocyte cultures from subjects sensitized to DNCB. Sequential studies of lymphocyte transformation to DNCB-antigen show that specifically reactive lymphocytes are first detected at about 10 days after in vivo application of a sensitizing dose of DNCB and reach a peak at about 14-21 days.

Authors

A. Edgar Miller, William R. Levis

×
Other pages:
1925 1926 1927 1928 1929 1930

Other pages:
1925 1926 1927 1928 1929 1930